Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.

High hyperdiploidy (HeH) (51 to 65 chromosomes) is found in one third of children with acute lymphoblastic leukemia and is associated with a good prognosis. Cytogenetic features may further refine this prognosis and identify patients with a poor outcome. We examined the effect of sex, age, individua...

Full description

Bibliographic Details
Main Authors:	Moorman, A, Richards, S, Martineau, M, Cheung, K, Robinson, H, Jalali, G, Broadfield, Z, Harris, R, Taylor, K, Gibson, B, Hann, I, Hill, F, Kinsey, SE, Eden, T, Mitchell, C, Harrison, C
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.
by: Moorman, A, et al.
Published: (2003)

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
by: Robinson, H, et al.
Published: (2003)

Intraocular relapse of childhood acute lymphoblastic leukemia.
by: Somervaille, T, et al.
Published: (2002)

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis
by: Moorman, A, et al.
Published: (2005)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.
by: Harrison, C, et al.
Published: (2004)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials.
by: Harrison, C, et al.
Published: (2003)

Hyperdiploid chromosomes in patients with B cell Acute lymphoblastic leukemia
by: Anjali Shastry
Published: (2024-02-01)

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
by: Moorman, A, et al.
Published: (2007)

Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants
by: Lisa Zipper, et al.
Published: (2024-01-01)

Prognostic determinants after intensified therapy of childhood lymphoblastic leukemia.
by: Vora, A, et al.
Published: (2000)

Intraocular relapse of childhood acute lymphoblastic leukaemia.
by: Somervaille, T, et al.
Published: (2003)

The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
by: Anna Østergaard, et al.
Published: (2023-05-01)

Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases.
by: Harewood, L, et al.
Published: (2003)

Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high‐hyperdiploid B‐cell acute lymphoblastic leukemia
by: Mireia Ramos‐Muntada, et al.
Published: (2022-08-01)

MRC ALL97/99 - A randomized comparison of dexamethasone versus prednisolone and thioguanine versus mercaptopurine in the treatment of childhood acute lymphoblastic leukemia.
by: Mitchell, C, et al.
Published: (2002)

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
by: Hill, F, et al.
Published: (2004)

Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia.
by: Clark, R, et al.
Published: (2000)

Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia
by: Danielle Brandes, et al.
Published: (2023-08-01)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
by: Hann, I, et al.
Published: (2000)

Genetic and regulatory mechanism of susceptibility to high-hyperdiploid acute lymphoblastic leukaemia at 10p21.2
by: Studd, J, et al.
Published: (2017)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
by: Mitchell, C, et al.
Published: (2005)

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
by: Vora, A, et al.
Published: (2006)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
by: Kinsey, S, et al.
Published: (2002)

ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
by: Martineau, M, et al.
Published: (2005)

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.
by: Ensor, H, et al.
Published: (2011)

Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
by: Hargrave, DR, et al.
Published: (2001)

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
by: Moorman, A, et al.
Published: (2010)

A third intensive block of treatment at 35 weeks improves outcome in childhood ALL: Preliminary results from the UKALLXI and ALL97 randomised trials.
by: Richards, S, et al.
Published: (1998)

Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
by: Krishnan, S, et al.
Published: (2010)

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.
by: Moorman, A, et al.
Published: (2014)

Comparison of high dose methotrexate with continuing intrathecal methotrexate versus intrathecal methotrexate alone in low white blood count childhood acute lymphoblastic leukaemia: Preliminary results from the UKALLXI randomised trial.
by: Hill, F, et al.
Published: (1998)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
by: Lennard, L, et al.
Published: (2005)

UKALL XI randomised trial stratified CNS treatments and prospective neuropsychological assessment in childhood acute lymphoblastic leukaemia (ALL).
by: Hill, F, et al.
Published: (2000)

ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia
by: Al-Obaidi, M, et al.
Published: (2002)

Late relapsing childhood lymphoblastic leukemia.
by: Vora, A, et al.
Published: (1998)

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics
by: Moorman, A, et al.
Published: (2012)

Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001.
by: Mitchell, C, et al.
Published: (2010)

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)
by: Moorman, A, et al.
Published: (2008)

Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI.
by: Wheeler, K, et al.
Published: (2000)

Blast cell vacuoles in childhood lymphoblastic leukaemia.
by: Lilleyman, J, et al.
Published: (1988)